Table 1 Characteristics of studies.
Characteristics | No. (19 studies) | % |
|---|---|---|
Publication year | ||
2010–2023 | 14 | 73.7 |
2000–2009 | 2 | 10.5 |
Before 2000 | 3 | 15.8 |
Study designs | ||
Cross-sectional studies | 12 | 63.2 |
Cohort study | 4 | 21.1 |
Case–control studies | 3 | 15.8 |
Study areas | ||
Africa | 8 | 42.1 |
Nigeria | 5 | 62.5 |
Cameroon | 1 | 12.5 |
Ethiopia | 1 | 12.5 |
Mali | 1 | 12.5 |
Asia | 11 | 57.9 |
India | 9 | 81.8 |
Turkey | 1 | 9.10 |
Thailand | 1 | 9.10 |
Plasmodium species | ||
P. falciparum | 10 | 52.6 |
P. falciparum, P. vivax | 3 | 15.8 |
P. falciparum, P. vivax, mixed infections | 2 | 10.5 |
P. vivax | 2 | 10.5 |
Not specified | 2 | 10.5 |
Participants | ||
Children | 6 | 31.6 |
Adults | 8 | 42.1 |
All age groups | 2 | 10.5 |
Not specified | 3 | 15.8 |
Methods for Plasmodium detection | ||
Microscopy | 12 | 63.2 |
Microscopy/RDT | 4 | 21.1 |
Microscopy/QBC/RDT | 1 | 5.26 |
Not specified | 2 | 10.5 |
Blood sample for UA measurement | ||
Serum | 8 | 42.1 |
Plasma | 8 | 42.1 |
Not specified | 3 | 15.8 |
